Mercaptopurine Tablets IP 50 mg (6-MP)

Mercaptopurine 50 mg Tablets (6-MP) are prescription antimetabolite medications used primarily in the treatment of certain types of leukemia, particularly acute lymphoblastic leukemia (ALL). This medication interferes with cancer cell growth and is typically administered as part of combination chemotherapy regimens under strict oncology supervision.

Mercaptopurine is a potent cytotoxic agent and must be used only under the guidance of a qualified healthcare provider experienced in cancer therapy.

📑 Table of Contents

1. Overview
2. Uses of Mercaptopurine 50 mg Tablets
3. Dosage Information
4. Mechanism of Action
5. Side Effects
6. Precautions and Warnings
7. Storage Instructions

Overview

Mercaptopurine 50 mg Tablets belong to a class of medications known as purine analog antimetabolites. These drugs work by disrupting the synthesis of DNA and RNA, thereby inhibiting the growth of rapidly dividing cells such as cancer cells.

Because of its immunosuppressive and cytotoxic properties, treatment requires regular laboratory monitoring, including complete blood counts and liver function tests.

For authoritative oncology drug information, refer to the U.S. Food & Drug Administration (FDA):
https://www.fda.gov/drugs

Uses of Mercaptopurine 50 mg Tablets

Mercaptopurine 50 mg Tablets are indicated for:

• Maintenance therapy in acute lymphoblastic leukemia (ALL)
• Use in combination chemotherapy protocols for hematologic malignancies
• Certain off-label uses in autoimmune disorders (only when prescribed and monitored by specialists)

It is not intended for casual or unsupervised use. Treatment protocols are individualized based on patient-specific factors including age, weight, and laboratory findings.

Dosage Information

Mercaptopurine 50 mg Tablets are administered orally. Dosing schedules are carefully calculated by oncology specialists and may vary depending on treatment phase and patient response.

Important considerations include:

• Regular blood tests to monitor bone marrow suppression
• Dose adjustments based on white blood cell counts
• Consideration of genetic enzyme deficiencies (such as TPMT deficiency)
• Close monitoring for liver toxicity

Patients should never alter dosage without medical instruction. Overdose or improper use can result in severe toxicity.

How Mercaptopurine 50 mg Tablets Work

Mechanism of Action of Mercaptopurine 50 mg Tablets

Mercaptopurine is a thiopurine analog that interferes with purine nucleotide synthesis.

Its action includes:

• Incorporation into DNA and RNA
• Inhibition of purine biosynthesis
• Suppression of rapidly dividing malignant cells

By disrupting cellular replication, Mercaptopurine 50 mg Tablets help control leukemia progression when used as part of a structured treatment plan.

Side Effects

Due to its cytotoxic nature, Mercaptopurine 50 mg Tablets may cause significant adverse effects.

Common Side Effects

• Nausea
• Vomiting
• Loss of appetite
• Fatigue
• Mild liver enzyme elevation

Serious Side Effects

• Bone marrow suppression (low white blood cells, anemia, thrombocytopenia)
• Increased risk of infections
• Hepatotoxicity
• Pancreatitis
• Secondary malignancies (rare but reported)

Immediate medical attention is required if signs of infection, unusual bruising, persistent fever, or jaundice occur.

Precautions and Warnings

Before initiating Mercaptopurine 50 mg Tablets, healthcare providers assess:

• Liver function
• Bone marrow function
• Genetic TPMT enzyme activity
• Current medications

Drug Interactions

Mercaptopurine may interact with:

• Allopurinol (dose adjustment required)
• Warfarin
• Other immunosuppressants
• Live vaccines

Concomitant use requires careful monitoring to reduce toxicity risk.

Pregnancy and Fertility

Mercaptopurine may cause fetal harm. Effective contraception is recommended during treatment and as advised by healthcare providers. Patients should discuss fertility considerations before starting therapy.

Storage Instructions

• Store at room temperature away from moisture and light
• Keep tablets in original packaging
• Keep out of reach of children
• Dispose of unused medication according to oncology safety guidelines